IMPAACT P1077 The PROMISE Study
(PROMOTING MATERNAL AND INFANT SURVIVAL EVERYWHERE)
This training was coordinated and conducted in collaboration between the Training and Education Resource Committee, the IMPAACT Resource Committees, and the P1077 (PROMISE) Protocol Team
Protocol Chair: Mary Glenn Fowler, M.D., M.P.H.
Protocol Co-Vice Chair: Tsungai Chipato, M.B. Ch.B.
Protocol Co-Vice Chair: James McIntyre, M.D.
- “PROMISE - Introduction to P1077, PROMISE Protocol” – Power Point
|
- “PROMISE Overview of Maternal and Infant Health Components” – Mary Glenn Fowler, M.D., M.P.H. – Power Point
|
- “PROMISE for Newbies” - Patricia Flynn, M.D. – Power Point
|
- “IMPAACT 1084s Maternal Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The bone and Kidney Health Substudy of 1077 PROMISE” - George Siberry, M.D. – Power Point
|
- “P1077 Protocol Training PROMISE” - Maripat Toye, R.N., M.S. & Missie Allen – Power Point
|
- “PROMISE Pharmacy Requirements” - Vivian Rexroad, Pharm.D. – Power Point
|
- “Data Management Overview” - Michael Basar, B.A. & Laura Smith, M.P.H. – Power Point
|
